Monopar Therapeutics (MNPR) insider trading
Every open-market stock purchase and sale by Monopar Therapeutics executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $105K over the last 12 months (1 buy).
- Insiders sold $344K over the last 12 months (1 sale).
- Last insider buy: Quan Anh Vu (CFO), $105K, 9 months ago.
Last 12 months: insiders bought $105K (1 buy) and sold $344K (1 sale). Last close $59.48 on Jun 4, 2026.
Recent MNPR insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Jun 26, 2026 | Nicole Sweeny (Director) | Bought (not open market) | — |
| Mar 31, 2026 | Chandler Robinson (CEO) | Sold (not open market) | $108K |
| Mar 31, 2026 | Andrew Cittadine (COO) | Sold (not open market) | $86.1K |
| Mar 31, 2026 | Andrew Cittadine (COO) | Bought (not open market) | — |
| Mar 31, 2026 | Chandler Robinson (CEO) | Bought (not open market) | — |
| Mar 2, 2026 | Susan Rodriguez (Officer) | Bought (not open market) | — |
| Jan 1, 2026 | Patrice Rioux (Insider) | Bought (not open market) | — |
| Dec 31, 2025 | Chandler Robinson (CEO) | Sold (not open market) | $167K |
| Dec 31, 2025 | Andrew Cittadine (COO) | Sold (not open market) | $123K |
| Dec 31, 2025 | Andrew Cittadine (COO) | Bought (not open market) | — |
| Dec 31, 2025 | Chandler Robinson (CEO) | Bought (not open market) | — |
| Dec 26, 2025 | Quan Anh Vu (CFO) | Bought | $105K |
| Dec 18, 2025 | Arthur J Klausner (Director) | Sold | $312K |
| Dec 18, 2025 | Arthur J Klausner (Director) | Sold | $31.4K |
| Dec 16, 2025 | Diane Hendricks (10% owner) | Sold (not open market) | — |
| Dec 16, 2025 | Arthur J Klausner (Director) | Bought (not open market) | — |
| Dec 2, 2025 | Quan Anh Vu (CFO) | Bought (not open market) | — |
| Dec 2, 2025 | Lavina Talukdar (Director) | Bought (not open market) | — |
| Dec 2, 2025 | Kim R Tsuchimoto (Director) | Bought (not open market) | — |
| Dec 2, 2025 | Quan Anh Vu (CFO) | Bought (not open market) | — |
| Dec 2, 2025 | Arthur J Klausner (Director) | Bought (not open market) | — |
| Dec 2, 2025 | Raymond Anderson (Director) | Bought (not open market) | — |
| Dec 2, 2025 | Andrew Cittadine (COO) | Bought (not open market) | — |
| Dec 2, 2025 | Andrew Cittadine (COO) | Bought (not open market) | — |
| Dec 2, 2025 | Christopher M Starr (Director) | Bought (not open market) | — |
Who's trading MNPR
- Nicole Sweeny, Director: other filings, last Jun 26, 2026
- Andrew Cittadine, COO: other filings, last Mar 31, 2026
- Chandler Robinson, CEO: other filings, last Mar 31, 2026
- Susan Rodriguez, Officer: other filings, last Mar 2, 2026
- Patrice Rioux, Insider: other filings, last Jan 1, 2026
- Quan Anh Vu, CFO: bought $105K (1 buy), last Dec 26, 2025
- Arthur J Klausner, Director: sold $344K (2 sales), last Dec 18, 2025
- Diane Hendricks, 10% owner: other filings, last Dec 16, 2025
- Raymond Anderson, Director: other filings, last Dec 2, 2025
- Christopher M Starr, Director: other filings, last Dec 2, 2025
- Kim R Tsuchimoto, CFO: other filings, last Dec 2, 2025
- Lavina Talukdar, Director: other filings, last Dec 2, 2025
Get free alerts when an insider at Monopar Therapeutics files a new trade →